Skip to Content


Advisory Committees; Tentative Schedule of Meetings for 2005

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


Food and Drug Administration, HHS.




The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 2005. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of the IOM's recommendations was for the agency to publish an annual tentative schedule of its meetings in the Federal Register. This publication implements the IOM's recommendation.

Start Further Info


Theresa L. Green, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

End Further Info End Preamble Start Supplemental Information


The IOM, at the request of the Commissioner, undertook a study of the use of FDA's advisory committees. In its final report in 1992, one of the IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Federal Register; FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Because the schedule is tentative, amendments to this notice will not be published in the Federal Register. However, changes to the schedule will be posted on the FDA advisory committees' Internet site located at​oc/​advisory/​default.htm. FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).

The following list announces FDA's tentatively scheduled advisory committee meetings for 2005. You may also obtain up-to-date meeting information by calling the Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area).

Committee NameTentative Date(s) of MeetingsAdvisory Committee 10-Digit Information Line Code
Pediatric Advisory CommitteeFebruary 14-15, June-day to be announced, November-day to be announced8732310001
Science Board to the Food and Drug AdministrationApril 15, November-day to be announced3014512603
Allergenic Products Advisory CommitteeApril 73014512388
Cellular, Tissue and Gene Therapies Advisory Committee (formerly Biological Response Modifiers Advisory Committee)March 3-4, July 28-29, November 9-103014512389
Blood Products Advisory CommitteeMarch 17-18, July 21-22, December 1-23014519516
Transmissible Spongiform Encephalopathies Advisory CommitteeFebruary 8-9, June 28-29, October 27-283014512392
Vaccines and Related Biological Products Advisory CommitteeFebruary 16-17, March 15-16, May 4-5, September 20-21, November 16-173014512391
Anesthetic and Life Support Drugs Advisory CommitteeMay 24-25, July 20-21, November 9-103014512529
Anti-Infective Drugs Advisory CommitteeTo Be Announced3014512530
Antiviral Drugs Advisory CommitteeMarch 10-11, August 3-43014512531
Arthritis Advisory CommitteeFebruary 16-17, May 12-13, September 15-163014512532
Start Printed Page 75986
Cardiovascular and Renal Drugs Advisory CommitteeFebruary 24, April 5-6, June 15-16, August 17-18, November 16-173014512533
Dermatologic and Ophthalmic Drugs Advisory CommitteeMarch 24-25—Joint Meeting with Nonprescription Drugs Advisory Committee, June 2-3, October 20-21, November 3-43014512534
Drug Safety and Risk Management Advisory CommitteeMarch 8-9—Joint Meeting with Gastrointestinal Drugs Advisory Committee, June 2-3, October 20-21, November 3-43014512535
Endocrinologic & Metabolic Drugs Advisory CommitteeJanuary 13-14—Joint Meeting with Nonprescription Drugs Advisory Committee, May 5-6, September 22-23, December 13-143014512536
Gastrointestinal Drugs Advisory CommitteeMarch 9—Joint Meeting with Drug Safety and Risk Management Advisory Committee, March 10, October-day to be announced3014512538
Nonprescription Drugs Advisory CommitteeJanuary 13-14-Joint Meeting with Endocrinologic and Metabolic Drugs Advisory Committee March 23-25—Joint Meeting with Dermatologic and Ophthalmic Drugs Advisory Committee3014512541
Oncologic Drugs Advisory CommitteeMarch 2-3, May 11-12, September 13-14, December 7-83014512542
Peripheral and Central Nervous System DrugsMay 43014512543
Pharmaceutical Science, Advisory Committee for (Parent Committee)April, October—Parent Committee-days to be announced April, November—Clinical Pharmacology Subcommittee-days to be announced March, June, September—Manufacturing Subcommittee-days to be announced3014512539
Psychopharmacologic Drugs Advisory CommitteeTo be announced3014512544
Pulmonary-Allergy Drugs Advisory CommitteeApril 27-28, August 30-31, December 12-133014512545
Reproductive Health Drugs, Advisory Committee forTo be announced3014512537
Device Good Manufacturing Practice Advisory CommitteeDecember-day to be announced3014512398
Medical Devices Advisory Committee (Comprised of 18 Panels)
Anesthesiology and Respiratory Therapy Devices PanelApril 25-26, November 3-43014512624
Circulatory System Devices PanelJanuary 13, March 17, May 19, July 21, September 22, November 173014512625
Clinical Chemistry and Clinical Toxicology Devices PanelMarch 21-22, April 21-22, May 23-24, July 11-12, September 8-9, December 5-63014512514
Dental Products PanelApril 11-12, July 18-193014512518
Ear, Nose, and Throat Devices PanelFebruary 24-25, April 28-29, June 20-21, August 1-2, October 6-7, December 1-23014512522
Gastroenterology-Urology Devices PanelMarch 4, May 3, July 22, October 213014512523
General and Plastic Surgery Devices PanelFebruary 7-8, June 9-10, August 25-26, November 7-83014512519
General Hospital and Personal Use Devices PanelFebruary 10-11, May 9-10, August 8-9, December 5-63014512520
Hematology and Pathology Devices PanelApril 29, October 213014512515
Immunology Devices PanelMay 19, November 103014512516
Start Printed Page 75987
Medical Devices Dispute Resolution PanelMeeting(s) scheduled as needed3014510232
Microbiology Devices PanelMarch 31-April 1, June 16-17, September 19-20, December 8-93014512517
Molecular and Clinical Genetics PanelApril 18-19, October 17-183014510231
Neurological Devices PanelApril 28-29, June 20-21, September 22-23, December 1-23014512513
Obstetrics and Gynecology Devices PanelMarch 10-11, May 16-17, August 15-16, November 14-153014512524
Ophthalmic Devices PanelMarch 17-18, May 12-13, July 28-29, September 29-30, November 17-183014512396
Orthopaedic and Rehabilitation Devices PanelJanuary 31-February 1, April 7-8, July 25-26, November 3- 43014512521
Radiological Devices PanelFebruary 1, May 10, August 2, November 13014512526
National Mammography Quality Assurance Advisory CommitteeApril 183014512397
Technical Electronic Product Radiation Safety Standards CommitteeMay 183014512399
Food Advisory Committee—ParentJuly-day to be announced3014510564
Additives and Ingredients SubcommitteeJune-day to be announcedDo.
Biotechnology SubcommitteeJuly-day to be announcedDo.
Contaminants and Natural Toxicants SubcommitteeNovember-day to be announcedDo.
Dietary Supplements SubcommitteeTo be announcedDo.
Infant Formula SubcommitteeAugust-day to be announcedDo.
Nutrition SubcommitteeTo be announcedDo.
Veterinary Medicine Advisory CommitteeJanuary 31, May 19, October 203014512548
Science Advisory Board to NCTRMarch 30-313014512559
Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and ContaminantsMay, September, November-days to be announced3014512560
Start Signature

Dated: December 8, 2004.

Sheila Dearybury Walcoff,

Associate Commissioner for External Relations.

End Signature End Supplemental Information

[FR Doc. 04-27737 Filed 12-17-04; 8:45 am]